NASDAQ Equity Snapshot
KROS Weekly Equity Report
Keros Therapeutics Inc
What the company does
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with a great unmet medical need. The company is headquartered in Lexington, Massachusetts.
What the weekly tape is saying
KROS closed the latest completed week at 10.15 USD. The 4-week return is -3.3% and the 12-week return is -7.4%. Trend Signal is inactive, Market Dynamics is -0.23. Setup signature: Risk-first tape with a 24/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 14.83 USD
- Vs Trend Line
- -31.5%
- Fair Value
- 30.98 USD
- Vs Fair Value
- -67.2%
- 52W High
- 22.55 USD
- 52W Low
- 9.69 USD
- Drawdown
- -55.0%
- Range Position
- 3.6%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 33
- 52W Active Breadth
- 63.5%
- Sector Scope
- US Healthcare
- Sector Rank
- 666 of 1038
- Sector Percentile
- 35.9%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
US Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 0.8%
- Avg 4W
- 3.5%
- Trend Breadth
- 33.0%
- Positive MD
- 41.0%
US Biotechnology
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 4.9%
- Avg 4W
- 1.7%
- Trend Breadth
- 46.0%
- Positive RS
- 47.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.23
- 4W MD Change
- 70.7%
- Relative Strength
- -42.69
- 4W RS Change
- -1.7%
- Expectation
- Negative
- Probability
- 44.41%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 967.2K
- 13W Average
- 1.8M
- 52W Average
- 2.7M
- Vs 13W
- 0.5x
- Vs 52W
- 0.4x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 6.5%
- 52W Volatility
- 7.0%
- Upside Weeks
- 22
- Downside Weeks
- 29
- Downside Breadth
- 55.8%
- Avg Gain / Loss
- 5.4% / -4.6%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NASDAQ
- Country
- US
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
- Market Cap
- 222.7M
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 10.15 USD | -1.5% | 14.83 USD | 30.98 USD | -0.23 | -42.69 | 967.2K | Off |
| 5 Jun 2026 | 10.30 USD | -8.4% | 15.06 USD | 31.16 USD | -0.33 | -41.05 | 1.1M | Off |
| 29 May 2026 | 11.25 USD | 0.5% | 15.26 USD | 31.37 USD | -0.41 | -39.17 | 1.0M | Off |
| 22 May 2026 | 11.19 USD | 6.6% | 15.39 USD | 31.62 USD | -0.59 | -38.31 | 2.0M | Off |
| 15 May 2026 | 10.50 USD | -13.0% | 15.52 USD | 31.86 USD | -0.78 | -41.99 | 2.2M | Off |
| 8 May 2026 | 12.07 USD | 5.0% | 15.63 USD | 32.11 USD | -0.90 | -34.15 | 1.6M | Off |
| 1 May 2026 | 11.49 USD | -0.2% | 15.75 USD | 32.32 USD | -1.03 | -34.41 | 1.4M | Off |
| 24 Apr 2026 | 11.51 USD | -1.4% | 15.90 USD | 32.53 USD | -1.06 | -33.92 | 1.2M | Off |
| 17 Apr 2026 | 11.67 USD | 4.1% | 16.05 USD | 32.74 USD | -1.13 | -32.09 | 1.7M | Off |
| 10 Apr 2026 | 11.21 USD | -6.6% | 16.18 USD | 32.95 USD | -1.13 | -31.45 | 1.8M | Off |
| 2 Apr 2026 | 12.00 USD | 13.1% | 16.33 USD | 33.13 USD | -1.14 | -23.79 | 2.0M | Off |
| 27 Mar 2026 | 10.61 USD | -3.2% | 16.45 USD | 33.31 USD | -1.18 | -30.09 | 2.0M | Off |
| 20 Mar 2026 | 10.96 USD | -0.5% | 16.61 USD | 33.51 USD | -1.17 | -30.33 | 4.0M | Off |
| 13 Mar 2026 | 11.02 USD | -2.5% | 16.76 USD | 33.71 USD | -1.18 | -31.55 | 3.2M | Off |